A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment
A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With MVA-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in HIV-1 Infected Adults on Suppressive ART
Sponsor: Beth Israel Deaconess Medical Center
A PHASE1 clinical study on Human Immunodeficiency Virus, this trial is completed. The trial is conducted by Beth Israel Deaconess Medical Center and has accumulated 21 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
21 versions recorded-
Mar 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Mar 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Dec 2021 — Mar 2022 [monthly]
Active Not Recruiting PHASE1
▶ Show 16 earlier versions
-
Nov 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE1
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE1
-
Feb 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Sep 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1
-
Jul 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2020 — Jul 2020 [monthly]
Recruiting PHASE1
-
Jun 2019 — Apr 2020 [monthly]
Recruiting PHASE1
-
Apr 2019 — Jun 2019 [monthly]
Recruiting PHASE1
-
Dec 2018 — Apr 2019 [monthly]
Recruiting PHASE1
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE1
-
Aug 2018 — Nov 2018 [monthly]
Recruiting PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Nov 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1
-
Oct 2017 — Nov 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beth Israel Deaconess Medical Center
- Janssen Vaccines & Prevention B.V.
- Ragon Institute of MGH, MIT and Harvard
- US Military HIV Research Program
For direct contact, visit the study record on ClinicalTrials.gov .